Clinical Research

Positive DSMB Review Of Ongoing RetinoStat And StarGen Clinical Studies

Oxford BioMedica plc biopharmaceuticals and its partner Sanofi announced a positive interim review of the RetinoStat(R) Phase I study in neovascular "wet" age-related macular degeneration (AMD) and the StarGen(TM) Phase I/IIa study in Stargardt ...

Article - News Staff - Aug 10 2012 - 11:30pm

BET Protein Inhibitor RVX-208 Meets Primary Endpoint In SUSTAIN Clinical Trial

...

Article - News Staff - Sep 1 2012 - 4:30am

Multiple Abortions Increase Risks For Subsequent Delivered Babies

A large study published in Human Reproduction (1) looked at the effect of induced abortions on a subsequent first birth and found that women who have had three or more abortions have a higher risk of adverse birth outcomes, such as delivering premature and ...

Article - News Staff - Aug 29 2012 - 6:49pm

Your Bones May Be Getting Fatter Too

Obesity is not just happening in New York City 7-Elevens(1), it is also happening in aging bones. Bone marrow stem cells, which are adult stem cells, are in their fifth decade of uncontroversial new discovery. But they can still surprise us.  Our bones may ...

Article - Hank Campbell - Sep 2 2012 - 2:01pm

Robot Technology Performs Complex Spinal Surgery On 10-Year-old

 Apollo Hospitals performed a complex spinal surgery on a 10-year-old child, the 12th successful surgery done within 10 days of the launch of Renaissance Robotic Technology, the only technology specifically designed for spine surgery. Apollo Hospitals Gro ...

Article - News Staff - Oct 6 2012 - 2:00pm

NA-1: Clinical Trial Shows Neuroprotectant Drug Protects Brain Against Stroke Damage

A neuroprotectant drug has been shown to protect the human brain against the damaging effects of stroke. The clinical trial was a randomized, double blind, multi-center trial that was conducted in Canada and the USA. The study evaluated the effectiveness o ...

Article - News Staff - Oct 9 2012 - 9:28am

First Patient In Randomized Controlled Hypertension Trial Of AV-Coupler Enrolled

...

Article - News Staff - Oct 20 2012 - 1:30pm

Data On Mucosal Healing With HUMIRA In Patients With Active Ulcerative Colitis

...

Article - News Staff - Oct 24 2012 - 9:56am

Phase II All-oral Study Of Simeprevir And VX-135 For The Treatment Of Hepatitis C

Medivir AB has announced plans for a phase II proof-of-concept study of an all-oral regimen for the treatment of hepatitis C containing of Medivir/Janssen's protease inhibitor simeprevir and Vertex's nucleotide analogue hepatitis C virus (HCV) p ...

Article - News Staff - Nov 3 2012 - 1:00pm

Phase 2 Study Of Zerenex For Treatment Of Non-Dialysis Dependent Chronic Kidney Disease Initiated

Keryx Biopharmaceuticals, Inc. has announced the initiation of a Phase 2 study of Zerenex (ferric citrate), an ferric iron-based phosphate binder drug candidate, in managing serum phosphorus and iron deficiency in anemic patients with Stage 3 to 5 non-dia ...

Article - News Staff - Nov 3 2012 - 12:00pm